FOLLOW US

  • facebook
  • twitter
Thu

March 12, 2026

AstraZeneca acquires Amolyt in $1B deal

America March 14, 2024

AstraZeneca acquires Amolyt in $1B deal

AstraZeneca, a pharmaceutical giant, announced on Thursday its acquisition of Amolyt Pharma, a clinical stage biotechnology company, in a deal…

By Rihem Akkouche

BioMerieux acquires Lumed

America January 8, 2024

BioMerieux Acquires Canada Tech Biz For €9M

In a groundbreaking development, BioMerieux has expanded its initial 16% stake in Lumed, solidifying its grip on the Canadian clinical…

By Rihem Akkouche

Zymergen Gets OK For Asset Sales

America December 19, 2023

Zymergen Gets OK For Asset Sales : Dramatic Bankruptcy Battle

In a courtroom drama that unfolded on Tuesday, a Delaware bankruptcy judge, Karen B. Owens, signaled her approval for biotechnology…

By Rihem Akkouche

Guardant Health $83M appeal

America November 15, 2023

Guardant Health $83M Appeal After Patent Verdict

Silicon Valley cancer diagnostics trailblazer, Guardant Health, is gearing up for an intense legal tussle as it appeals an adverse…

By Rihem Akkouche

Abrdn Buys £2.6B Health Care

America October 30, 2023

Abrdn £2.6B Health Care Fund :

In a stunning financial maneuver, Abrdn, the renowned investment powerhouse, has unleashed a dazzling financial onslaught by acquiring the health…

By Rihem Akkouche

Abivaxs $236M US IPO

America October 20, 2023

Abivax $236M US IPO : Resilient Amidst Legal Guidance

In a thrilling turn of events, the Paris-based biotechnology firm Abivax SA defied market perplexity as it successfully raised $236…

By Rihem Akkouche

Signup for the USA Herald
exclusive Newsletter